Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medite Cancer Diagnostics Inc (MDIT)
OTHER OTC:MDIT
Medite Cancer Diagnostics (MDIT) Stock Price & Analysis
4 Followers
MDIT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.01
Previous Close$0.01
Volume10.00
Average Volume (3M)1.92K
Market Cap
$8.62K
Enterprise Value$6.93M
Total Cash (Recent Filing)$90.00K
Total Debt (Recent Filing)$6.05M
Price to Earnings (P/E)N/A
Beta87.55
Next Earnings
Aug 14, 2017EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume1,918
Standard Deviation19.31
R-Squared0.05
Alpha2.68
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.85
Enterprise Value/Gross Profit42.79
Enterprise Value/Ebitda-1.96
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MDIT FAQ
What was Medite Cancer Diagnostics Inc’s price range in the past 12 months?
Medite Cancer Diagnostics Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Medite Cancer Diagnostics Inc’s market cap?
Currently, no data Available
When is Medite Cancer Diagnostics Inc’s upcoming earnings report date?
Medite Cancer Diagnostics Inc’s upcoming earnings report date is Aug 14, 2017 which is 2459 days ago.
How were Medite Cancer Diagnostics Inc’s earnings last quarter?
Currently, no data Available
Is Medite Cancer Diagnostics Inc overvalued?
According to Wall Street analysts Medite Cancer Diagnostics Inc’s price is currently Overvalued.
Does Medite Cancer Diagnostics Inc pay dividends?
Medite Cancer Diagnostics Inc does not currently pay dividends.
What is Medite Cancer Diagnostics Inc’s EPS estimate?
Medite Cancer Diagnostics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medite Cancer Diagnostics Inc have?
Medite Cancer Diagnostics Inc has 86,196,700 shares outstanding.
What happened to Medite Cancer Diagnostics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medite Cancer Diagnostics Inc?
Currently, no hedge funds are holding shares in MDIT
---
Company Description
Medite Cancer Diagnostics Inc
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. It specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland. The company was founded in December 1998 and is headquartered in Orlando, FL.
---
Technical Analysis
---